control group:Bismuth agent combined with triple therapy (nexium, amoxicillin and furazolidone)

2 trials

Sponsors

Department of Gastroenterology, Run Run Shaw Hospital of Zhejiang University School of Medicine

Conditions

Heilicobacter pylori infection

Phase 4

Clinical study of Weierkang pills combined with triple therapy for Helicobacter pylori infection

Active, not recruitingITMCTR2000003109

Department of Gastroenterology, Run Run Shaw Hospital of Zhejiang University School of MedicineHeilicobacter pylori infection

Start: 2020-04-01Updated: 2023-02-20

Clinical study of Weierkang pills combined with triple therapy for Helicobacter pylori infection

Active, not recruitingChiCTR2000030775

Department of Gastroenterology, Run Run Shaw Hospital of Zhejiang University School of MedicineHeilicobacter pylori infection

Start: 2020-04-01Updated: 2020-03-16